Human medicines European public assessment report (EPAR): Cejemly, sugemalimab, Date of authorisation: 24/07/2024, Revision: 7, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 18 February 2026 - 8:30

Human medicines European public assessment report (EPAR): Cejemly, sugemalimab, Date of authorisation: 24/07/2024, Revision: 7, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/cejemly

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters